)
The drug discovery and development company has announced the departure of Thomas Liquard as CEO.
In the interim, former ACL CEO Tracie Ramsdale will step up from a non-executive director role into an executive director capacity.
The company noted in an announcement that Ramsdale’s leadership will help them during this transition, and ended with thanking Liquard “for his efforts and wishing him well for the future”.
Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support
)
)
)
)
)
